| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, New Ventures | Sell | 1,125 | $69.05 | $77,681.25 | -10.5% | -30.6% | -10.7% | |
| Feb 23, 2022 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 17,704 | $39.13 | $692,718.80 | -2.1% | -48.3% | -39.3% | |
| Feb 23, 2022 | EXAS Exact Sciences Corp | Condella Sarah75 | SVP, Human Resources | Sell | 1,124 | $69.05 | $77,612.20 | -1.3% | -30.6% | -10.7% | |
| Feb 22, 2022 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 17,436 | $288.67 | $5,033,328.22 | -1.0% | -20.1% | -24.3% | |
| Feb 22, 2022 | NOTV Inotiv, Inc. | Downing Philip A | Sr. VP, Preclinical Srvcs. | Buy | 2,000 | $23.97 | $47,945.60 | +5.0% | -48.8% | -71.7% | |
| Feb 22, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 1,280 | $52.66 | $67,404.80 | -0.5% | -28.2% | -60.0% | |
| Feb 22, 2022 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, New Ventures | Sell | 1,749 | $72.72 | $127,187.28 | -17.2% | -29.2% | -12.0% | |
| Feb 22, 2022 | CRL Charles River Laboratories International, Inc. | Wallman Richard F81 | Director | Sell | 7,200 | $292.84 | $2,108,412.50 | -15.5% | -20.1% | -24.3% | |
| Feb 22, 2022 | TWST Twist Bioscience Corp | Thorburn James M84 | Chief Financial Officer | Sell | 4,442 | $52.52 | $233,315.89 | -3.0% | -28.2% | -60.0% | |
| Feb 22, 2022 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 1,539 | $291.55 | $448,697.57 | -2.4% | -20.1% | -24.3% | |
| Feb 18, 2022 | NOTV Inotiv, Inc. | Taylor Beth54 | Vp- Finance &CFO | Buy | 5,000 | $23.07 | $115,357.50 | +6.3% | -20.9% | -68.1% | |
| Feb 18, 2022 | NOTV Inotiv, Inc. | Garrett Michael | Chief Commercial Officer | Buy | 1,000 | $23.50 | $23,500.00 | New | -20.9% | -68.1% | |
| Feb 18, 2022 | NOTV Inotiv, Inc. | Pitchford William D | Chief Hr Officer | Buy | 3,500 | $21.12 | $73,920.00 | +4.8% | -20.9% | -68.1% | |
| Feb 18, 2022 | NOTV Inotiv, Inc. | Davis Gregory Cole | Director | Buy | 5,000 | $22.39 | $111,927.50 | +4.9% | -20.9% | -68.1% | |
| Feb 18, 2022 | NOTV Inotiv, Inc. | Beattie John Gregory | Chief Operating Officer | Buy | 11,400 | $22.71 | $258,871.14 | +10.3% | -20.9% | -68.1% | |
| Feb 17, 2022 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Buy | 5,000 | $23.03 | $115,131.00 | +1.8% | -12.2% | -63.4% | |
| Feb 17, 2022 | MEDP Medpace Holdings, Inc. | Davenport Fred B Jr | Director | Buy | 500 | $145.80 | $72,900.00 | +33.3% | -7.6% | +45.1% | |
| Feb 17, 2022 | NOTV Inotiv, Inc. | Sagartz John E60 | Chief Strategy Officer | Buy | 2,506 | $19.95 | $49,998.71 | +0.4% | -12.2% | -63.4% | |
| Feb 16, 2022 | TWST Twist Bioscience Corp | Johannessen Jan71 | Director | Sell | 5,000 | $59.20 | $296,000.00 | -49.3% | -42.0% | -61.0% | |
| Feb 15, 2022 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 20,000 | $315.46 | $6,309,137.38 | -0.4% | -26.0% | -19.5% | |
| Feb 15, 2022 | MTD Mettler Toledo International Inc/ | Aggersbjerg Peter54 | Head Of Divisions | Sell | 694 | $1,424.29 | $988,457.26 | -100% | -13.7% | +9.2% | |
| Feb 15, 2022 | EXAS Exact Sciences Corp | Condella Sarah75 | SVP, Human Resources | Sell | 938 | $79.55 | $74,617.90 | -1.1% | -37.8% | -18.6% | |
| Feb 15, 2022 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,839 | $79.55 | $146,292.45 | -22.6% | -37.8% | -18.6% | |
| Feb 15, 2022 | EXAS Exact Sciences Corp | Coward D Scott77 | Chief Administrative Officer | Sell | 1,813 | $79.55 | $144,224.15 | -32.4% | -37.8% | -18.6% | |
| Feb 15, 2022 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, New Ventures | Sell | 940 | $79.55 | $74,777.00 | -12.6% | -37.8% | -18.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.